US Patent 10988455 1,2,4-triazine-4-amine derivatives
Patent 10988455 was granted and assigned to Heptares Therapeutics on April, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10988455 1,2,4-triazine-4-amine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.